Adagio Therapeutics

+$0.08 (+3.05%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADGI and other ETFs, options, and stocks.

About ADGI

Adagio Therapeutics, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses.

CEO
David Hering
Employees
103
Headquarters
Waltham, Massachusetts
Founded
2020

ADGI Key Statistics

Market cap
296.23M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.05M
High today
$2.74
Low today
$2.58
Open price
$2.60
Volume
588.83K
52 Week high
$78.82
52 Week low
$2.46

ADGI Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.93 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure